2014 Annual Shareholder Meeting Dwight Babcock, CEO
Dec 31, 2015
2014 Annual Shareholder Meeting
Dwight Babcock, CEO
Brien Ragle Bill Cavanagh
Dale Boyce Krista Cline
Herb Barbosa Clay OLaughlin
BRAIN
HEAD and NECK
LUNG
PROSTATE
GYNECOLOGY
1st Peer reviews Published1st Prostate Patient Reaches the 10 Year Mark1stStereotactic Brain Treatment Peru Child1stRussian Prostate Implants Performed1stLiquid Cs-131 GliaSite Case Performed1stProstate Case Utilizing C-4 MRI Markers1stVeterinary Case With Cs-131***Added to the Russell Microcap Listing
Metastatic Brain Cancer By Cornell Weill
Gynecologic CancerBy University of KentuckyProstate CancerBy University of Pittsburg
Prostate Seeds I-125 & P-103External Beam, Robotic Surgery Brain Cancers and Tumors External Beam, ChemotherapyLung Cancer Seeds I-125External BeamGynecologic Cancer External Bean
Pharma ModelProduct development and pre-human testing: 5 yearsHuman Clinical Trials: 5 yearsFDA Approval: 2 yearsAdoptionIsoRay Prostate ModelProduct development 510(k) FDA Approval 1-2 yearsEarly Adopters DataPublished Papers 5-6 yearsWider Scale AdoptionIsoRay New Product ModelProduct development 510(k) FDA Approval1-2 yearsEarly Adopters DataPublished Papers 2-5 yearsWider Scale Adoption
Thomas Jefferson Head & Neck CancerUPMC Focal Prostate StudyMoran Focal Prostate StudyBarrows Multiple Brain TumorsCornell Weill Lung CancerMD Anderson Prostate CancerSylvestor Dual Therapy Prostate CancerCole Mono Therapy Prostate Cancer
*